Phase I/II study of carboplatin and oral etoposide with granulocyte-colony stimulating factor in advanced nonsmall cell lung cancer

This publication has 11 references indexed in Scilit:

• Carboplatin plus Oral Etoposide in the Management of Unresectable Non-Small Cell Lung Cancer
  Oncology, 1992
• Cancer statistics, 1992
  CA: A Cancer Journal for Clinicians, 1992
• The Role of Systemic Chemotherapy in Non-Small Cell Lung Cancer
  Published by Springer Nature ,1991
• Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium
  New England Journal of Medicine, 1988
• EFFECT OF GRANULOCYTE COLONY STIMULATING FACTOR ON NEUTROPENIA INDUCED BY CYTOTOXIC CHEMOTHERAPY
  The Lancet, 1988
• Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer
  British Journal of Cancer, 1987
• A New International Staging System for Lung Cancer
  Chest, 1986
• Phase II trial of VP16-213 in non-small cell lung cancer (NSCLC)
  Cancer Chemotherapy and Pharmacology, 1982
• Reporting results of cancer treatment
  Cancer, 1981
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958